Suppr超能文献

胸腺内同种异体抗原介导的、耐受的、完全主要组织相容性复合体不匹配的小鼠心脏会被过继转移的抗I类L(d+)特异性2C细胞特异性排斥。

Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.

作者信息

Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye M W

机构信息

Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA.

出版信息

Surgery. 2000 Aug;128(2):206-12. doi: 10.1067/msy.2000.107377.

Abstract

BACKGROUND

Tolerance to cardiac allografts can be induced in mice and rats by the injection of donor alloantigen into the thymus in combination with a CD4 T-cell-depleting antibody. CD8(+) cells in these animals are hyporesponsive to graft-specific alloantigens. Most of the CD8(+) T cells in the transgenic 2C mouse express a T-cell receptor specific for the class I major histocompatibility complex L(d+) locus. This study was designed to determine whether the adoptive transfer of these 2C T cells could precipitate rejection of a tolerant, completely major histocompatibility complex-mismatched L(d+) or L(d-) heart.

METHODS

C57BL/6 mice (L(d-)) were given 10 x 10(6) cells of BALB/c (L(d+)) or dm2 (BALB/c background lacking L(d) [L(d-)]) splenocytes intrathymically and GK1. 5 (10 mg/kg) intraperitoneally. Twenty-one days later, BALB/c or dm2 hearts were transplanted. On the day of transplantation or after long-term allograft acceptance, recipients received naive 2C cells or 2C cells sensitized by in vitro mixed lymphocyte culture with BALB/c (L(d+)).

RESULTS

Mean survival time of BALB/c cardiac allografts in untreated C57BL/6 mice was 7.3 days, although 73% of the mice that were pretreated with BALB/c splenocytes IT plus GK1.5 accepted the donor antigen-specific heart allografts indefinitely. All recipients that were pretreated with the intrathymic plus GK1.5 and that were injected with naive 2C cells at the time of heart transplantation experienced rejection of the BALB/c (L(d+)), but not the dm2 (L(d-)) hearts. In contrast, naive 2C cells could not reject tolerant (>30 days acceptance) BALB/c (L(d+)) hearts. 2C cells sensitized in vitro against L(d) were able to reject established BALB/c hearts but could not reject the L(d-) dm2 hearts.

CONCLUSIONS

L(d)-specific 2C T-cell receptor transgenic T cells that are adoptively transferred to recipients will precipitate the rejection of accepted hearts that express class I L(d+) in mice rendered tolerant by an intrathymic injection of alloantigen plus anti-CD4 monoclonal antibodies.

摘要

背景

通过将供体同种异体抗原与一种耗竭CD4 T细胞的抗体联合注射到小鼠和大鼠的胸腺中,可诱导对心脏同种异体移植物的耐受性。这些动物体内的CD8(+)细胞对移植物特异性同种异体抗原反应低下。转基因2C小鼠中的大多数CD8(+) T细胞表达一种针对I类主要组织相容性复合体L(d+)位点的特异性T细胞受体。本研究旨在确定这些2C T细胞的过继转移是否会引发对已产生耐受性的、完全主要组织相容性复合体不匹配的L(d+)或L(d-)心脏的排斥反应。

方法

给C57BL/6小鼠(L(d-))胸腺内注射10×10(6)个BALB/c(L(d+))或dm2(缺乏L(d)的BALB/c背景[L(d-)])脾细胞,并腹腔注射GK1.5(10 mg/kg)。21天后,移植BALB/c或dm2心脏。在移植当天或长期同种异体移植物被接受后,受体接受未致敏的2C细胞或通过与BALB/c(L(d+))进行体外混合淋巴细胞培养而致敏的2C细胞。

结果

未处理的C57BL/6小鼠中BALB/c心脏同种异体移植物的平均存活时间为7.3天,尽管73%经BALB/c脾细胞胸腺内注射加GK1.5预处理的小鼠可无限期接受供体抗原特异性心脏同种异体移植物。所有经胸腺内加GK1.5预处理且在心脏移植时注射未致敏2C细胞的受体,其BALB/c(L(d+))心脏发生排斥反应,但dm2(L(d-))心脏未发生排斥反应。相反,未致敏的2C细胞不能排斥已产生耐受性(>30天接受)的BALB/c(L(d+))心脏。体外针对L(d)致敏的2C细胞能够排斥已建立的BALB/c心脏,但不能排斥L(d-) dm2心脏。

结论

过继转移给受体的L(d)特异性2C T细胞受体会引发对已被接受的、表达I类L(d+)的心脏的排斥反应,这些小鼠是通过胸腺内注射同种异体抗原加抗CD4单克隆抗体而产生耐受性的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验